Additional insights include vitamin utilisation, insulin sensitivity, bone strength, salt sensitivity, iron balance, oxidative stress response, and metabolism of lactose, caffeine, and alcoholfactors that directly impact resilience and long-term health
They work by: Helping to reduce appetite and food cravings Promoting earlier satiety Supporting better metabolic regulation GLP-1 medications are not cosmetic treatments and are not suitable for everyone
If you have severe gastrointestinal conditions such as gastroparesis, talk to your doctor before considering any GLP-1 based treatment
Tirzepatide, a dual GLP-1 and GIP receptor agonist, works differently than older weight-loss medications because it activates two hormone pathways simultaneously
In February 2025, Novo Nordisk reported a 30% Q4 2024 sales growth, reaching $12 billion , contributing to a 26% annual sales increase to nearly $41 billion
(2015) Transdermal drug delivery: Innovative pharmaceutical developments based on disruption of the barrier properties of the stratum corneum